Suchergebnisse - "Sorensen, Per Soelberg"

Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study von Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Adeniji, Abidemi K, Vermersch, Patrick

“… In the 2-year CLARITY study, cladribine tablets significantly improved clinical and magnetic resonance imaging (MRI) outcomes (vs placebo) in patients with …”
Weitere Angaben

The Multiple Sclerosis Care Unit von Soelberg Sorensen, Per, Giovannoni, Gavin, Montalban, Xavier, Thalheim, Christoph, Zaratin, Paola, Comi, Giancarlo

“… Treatment of multiple sclerosis (MS) has become increasingly multifaceted and comprises not only a variety of disease-modifying drugs with different mechanism …”
Weitere Angaben

Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19 von Sun, Shaoxiong, Folarin, Amos A, Ranjan, Yatharth, Rashid, Zulqarnain, Conde, Pauline, Stewart, Callum, Cummins, Nicholas, Matcham, Faith, Dalla Costa, Gloria, Simblett, Sara, Leocani, Letizia, Lamers, Femke, Sørensen, Per Soelberg, Buron, Mathias, Zabalza, Ana, Guerrero Pérez, Ana Isabel, Penninx, Brenda WJH, Siddi, Sara, Haro, Josep Maria, Myin-Germeys, Inez, Rintala, Aki, Wykes, Til, Narayan, Vaibhav A, Comi, Giancarlo, Hotopf, Matthew, Dobson, Richard JB

“… In the absence of a vaccine or effective treatment for COVID-19, countries have adopted nonpharmaceutical interventions (NPIs) such as social distancing and …”
Volltext

Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis von Comi, Giancarlo, Cook, Stuart, Giovannoni, Gavin, Rieckmann, Peter, Sørensen, Per Soelberg, Vermersch, Patrick, Galazka, Andrew, Nolting, Axel, Hicking, Christine, Dangond, Fernando

“… •Long-term lymphocyte counts were evaluated (CLARITY, CLARITY Extension and PREMIERE).•Absolute lymphocyte counts were evaluated to 312 weeks, B and T cells to …”
Volltext

Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review von Fernández, Óscar, Sörensen, Per Soelberg, Comi, Giancarlo, Vermersch, Patrick, Hartung, Hans-Peter, Leocani, Letizia, Berger, Thomas, Van Wijmeersch, Bart, Oreja-Guevara, Celia

“… Multiple Sclerosis (MS) management in individuals aged 55 and above presents unique challenges due to the complex interaction between aging, comorbidities, …”
Volltext

The gut microbiota in multiple sclerosis varies with disease activity von Thirion, Florence, Sellebjerg, Finn, Fan, Yong, Lyu, Liwei, Hansen, Tue H., Pons, Nicolas, Levenez, Florence, Quinquis, Benoit, Stankevic, Evelina, Søndergaard, Helle B., Dantoft, Thomas M., Poulsen, Casper S., Forslund, Sofia K., Vestergaard, Henrik, Hansen, Torben, Brix, Susanne, Oturai, Annette, Sørensen, Per Soelberg, Ehrlich, Stanislav D., Pedersen, Oluf

“… Background Multiple sclerosis is a chronic immune-mediated disease of the brain and spinal cord resulting in physical and cognitive impairment in young adults …”
Volltext

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study von Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick

“… In the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study, Cladribine Tablets significantly improved clinical and magnetic resonance imaging …”
Weitere Angaben

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study von Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin

“… Background The CLARITY and CLARITY Extension studies demonstrated that treatment of relapsing–remitting multiple sclerosis (RRMS) with cladribine tablets (CT) …”
Volltext

Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents von Blinkenberg, Morten, Soelberg Sørensen, Per

“… Treatment of multiple sclerosis (MS) has improved considerably over the last decade because of new insights into MS pathology and biotechnological advances …”
Volltext

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network von Signori, Alessio, Lorscheider, Johannes, Vukusic, Sandra, Trojano, Maria, Iaffaldano, Pietro, Hillert, Jan, Hyde, Robert, Pellegrini, Fabio, Magyari, Melinda, Koch-Henriksen, Nils, Sørensen, Per Soelberg, Spelman, Tim, van der Walt, Anneke, Horakova, Dana, Havrdova, Eva, Girard, Marc, Eichau, Sara, Grand'Maison, Francois, Gerlach, Oliver, Terzi, Murat, Ozakbas, Serkan, Skibina, Olga, Van Pesch, Vincent, Sa, Maria Jose, Prevost, Julie, Alroughani, Raed, McCombe, Pamela A, Gouider, Riadh, Mrabet, Saloua, Castillo-Trivino, Tamara, Zhu, Chao, de Gans, Koen, Sánchez-Menoyo, José Luis, Yamout, Bassem, Khoury, Samia, Sormani, Maria Pia, Kalincik, Tomas, Butzkueven, Helmut

“… BackgroundOver the decades, several natural history studies on patients with primary (PPMS) or secondary progressive multiple sclerosis (SPMS) were reported …”
Volltext

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis von Uccelli, Antonio, Laroni, Alice, Brundin, Lou, Clanet, Michel, Fernandez, Oscar, Nabavi, Seyed Massood, Muraro, Paolo A., Oliveri, Roberto S., Radue, Ernst W., Sellner, Johann, Soelberg Sorensen, Per, Sormani, Maria Pia, Wuerfel, Jens Thomas, Battaglia, Mario A., Freedman, Mark S.

“… Background Multiple sclerosis (MS) is an inflammatory disease of the central nervous system with a degenerative component, leading to irreversible disability …”
Volltext

Comorbidity in Multiple Sclerosis von Magyari, Melinda, Sorensen, Per Soelberg

“… Comorbidities in patients with multiple sclerosis (MS) has become an area of increasing interest in the recent years. A comorbidity is defined as any …”
Volltext

Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple Sclerosis von Kontaxis, Spyridon, Laporta, Estela, Garcia, Esther, Martinis, Matteo, Leocani, Letizia, Roselli, Lucia, Buron, Mathias Due, Guerrero, Ana Isabel, Zabala, Ana, Cummins, Nicholas, Vairavan, Srinivasan, Hotopf, Matthew, Dobson, Richard J. B., Narayan, Vaibhav A., La Porta, Maria Libera, Costa, Gloria Dalla, Magyari, Melinda, Sørensen, Per Soelberg, Nos, Carlos, Bailon, Raquel, Comi, Giancarlo

“… The aim of this study was to investigate the feasibility of automatically assessing the 2-Minute Walk Distance (2MWD) for monitoring people with multiple …”
Volltext

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis von Bachelet, Delphine, Hässler, Signe, Mbogning, Cyprien, Link, Jenny, Ryner, Malin, Ramanujam, Ryan, Auer, Michael, Hyldgaard Jensen, Poul Erik, Koch-Henriksen, Nils, Warnke, Clemens, Ingenhoven, Kathleen, Buck, Dorothea, Grummel, Verena, Lawton, Andy, Donnellan, Naoimh, Hincelin-Mery, Agnès, Sikkema, Dan, Pallardy, Marc, Kieseier, Bernd, Hemmer, Bernard, Hartung, Hans Peter, Soelberg Sorensen, Per, Deisenhammer, Florian, Dönnes, Pierre, Davidson, Julie, Fogdell-Hahn, Anna, Broët, Philippe

“… Immunogenicity of biopharmaceutical products in multiple sclerosis is a frequent side effect which has a multifactorial etiology. Here we study associations …”
Volltext

Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis von Kontaxis, Spyridon, Laporta, Estela, Garcia, Esther, Guerrero, Ana Isabel, Zabalza, Ana, Matteo, Martinis, Lucia, Roselli, Simblett, Sara, Weyer, Janice, Hotopf, Matthew, Narayan, Vaibhav A., Rashid, Zulqarnain, Folarin, Amos A., Dobson, Richard J. B., Buron, Mathias Due, Leocani, Letizia, Cummins, Nicholas, Vairavan, Srinivasan, Costa, Gloria Dalla, Magyari, Melinda, Sørensen, Per Soelberg, Nos, Carlos, Bailón, Raquel, Comi, Giancarlo, the RADAR-CNS Consortium

“… Objective: The aim of this study was to evaluate the association between changes in the autonomic control of cardiorespiratory system induced by walk tests and …”
Volltext

Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis von Laursen, Julie H, Søndergaard, Helle Bach, Albrechtsen, Anders, Frikke-Schmidt, Ruth, Koch-Henriksen, Nils, Soelberg Sørensen, Per, Sellebjerg, Finn, Oturai, Annette

“… Background: Evidence is accumulating supporting a beneficial effect of vitamin D in multiple sclerosis (MS). Genome-wide association studies (GWAS) have shown …”
Volltext

Evolving concepts in the treatment of relapsing multiple sclerosis von Comi, Giancarlo, Radaelli, Marta, Soelberg Sørensen, Per

“… In the past 20 years the treatment scenario of multiple sclerosis has radically changed. The increasing availability of effective disease-modifying therapies …”
Volltext

Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality von Thormann, Anja, Sørensen, Per Soelberg, Koch-Henriksen, Nils, Laursen, Bjarne, Magyari, Melinda

“… To investigate the effect of chronic comorbidity on the time of diagnosis of multiple sclerosis (MS) and on mortality in MS. We conducted a population-based, …”
Weitere Angaben

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview von Marrie, Ruth Ann, Cohen, Jeffrey, Stuve, Olaf, Trojano, Maria, Sørensen, Per Soelberg, Reingold, Stephen, Cutter, Gary, Reider, Nadia

“… Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS). Objective: The objective of this review is to estimate the incidence and …”
Volltext

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review von Marrie, Ruth Ann, Reingold, Stephen, Cohen, Jeffrey, Stuve, Olaf, Trojano, Maria, Sorensen, Per Soelberg, Cutter, Gary, Reider, Nadia

“… Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple …”
Volltext